Cancer-associated systemic sclerosis in a Canadian cohort: beyond strengths and weaknesses of epidemiological studies

Rheumatology (Oxford). 2022 Jul 6;61(7):2717-2719. doi: 10.1093/rheumatology/keab924.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Autoantibodies / immunology
  • Canada / epidemiology
  • Humans
  • Neoplasms*
  • Registries
  • Scleroderma, Systemic* / complications
  • Scleroderma, Systemic* / epidemiology
  • Scleroderma, Systemic* / immunology

Substances

  • Autoantibodies